Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Lottenberg

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Annals of Emergency Medicine|September 15, 2020
Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell DiseaseMatthew Lyon, Lashon Sturgis, Richard Lottenberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 23, 2013
Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug deliverySe-woon Choe, David S Terman, Angela E Rivers, et al.
American Journal of Hematology|June 2, 2005
Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologistsMarc S Zumberg, Suresh Reddy, Robert L Boyette, et al.
Journal of the National Medical Association|April 1, 2009
Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell diseaseJennifer M LaVista, Debbie M Treise, Levette N Dunbar, et al.
Blood Advances|September 22, 2023
ASH Clinical Practice Guidelines: strategies to stay up-to-dateMatthew C Cheung, Rob Kunkle, Rob Plovnick, et al.
The Journal of Trauma|August 10, 2011
A pilot study on the randomization of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patientsAnita Rajasekhar, Lawrence Lottenberg, Richard Lottenberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2014
Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoptionKathryn L Hassell, Araba Afenyi-Annan, Samir K Ballas, et al.
British Journal of Haematology|November 17, 2021
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherenceWally R Smith, Donna K McClish, Richard Lottenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2002
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL triggerMarc S Zumberg, Maria Luz U del Rosario, Christine F Nejame, et al.
Transplantation|March 30, 2002
Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case reportJuan M Aranda, Juan C Scornik, Sigurd J Normann, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Annals of Emergency Medicine|September 15, 2020
Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell DiseaseMatthew Lyon, Lashon Sturgis, Richard Lottenberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 23, 2013
Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug deliverySe-woon Choe, David S Terman, Angela E Rivers, et al.
American Journal of Hematology|June 2, 2005
Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologistsMarc S Zumberg, Suresh Reddy, Robert L Boyette, et al.
Journal of the National Medical Association|April 1, 2009
Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell diseaseJennifer M LaVista, Debbie M Treise, Levette N Dunbar, et al.
Blood Advances|September 22, 2023
ASH Clinical Practice Guidelines: strategies to stay up-to-dateMatthew C Cheung, Rob Kunkle, Rob Plovnick, et al.
The Journal of Trauma|August 10, 2011
A pilot study on the randomization of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patientsAnita Rajasekhar, Lawrence Lottenberg, Richard Lottenberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2014
Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoptionKathryn L Hassell, Araba Afenyi-Annan, Samir K Ballas, et al.
British Journal of Haematology|November 17, 2021
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherenceWally R Smith, Donna K McClish, Richard Lottenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2002
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL triggerMarc S Zumberg, Maria Luz U del Rosario, Christine F Nejame, et al.
Transplantation|March 30, 2002
Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case reportJuan M Aranda, Juan C Scornik, Sigurd J Normann, et al.
Pageof 4